Dicot Pharma

Uppsala, Sweden

Dicot Pharma, focused on drug discovery and development of a modern potency drug treating erectile dysfunction better than existing drugs.

$22.4M raised

Jun 2026

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Dicot Pharma raised?

Dicot Pharma has raised $22.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.

Who are Dicot Pharma's investors?

Dicot Pharma's investors include Almi Invest.

Where is Dicot Pharma headquartered?

Dicot Pharma is headquartered in Uppsala, Sweden.

What does Dicot Pharma do?

Dicot Pharma, focused on drug discovery and development of a modern potency drug treating erectile dysfunction better than existing drugs.

What stage is Dicot Pharma at?

Dicot Pharma is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 4, 2026.

MLA

"Dicot Pharma — Funding & Investors." VCBacked, June 4, 2026, https://www.vcbacked.co/company/dicot-pharma. Accessed July 1, 2026.

APA

VCBacked. (2026). Dicot Pharma — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/dicot-pharma

Wikipedia (cite web)

{{cite web |title=Dicot Pharma — Funding & Investors |url=https://www.vcbacked.co/company/dicot-pharma |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 4, 2026.